Key takeaway: On August 5, 2026, Godrej Agrovet Limited's Board of Directors approved the Standalone and Consolidated Unaudited Financial Results for the quarter ended June 30, 2026. The investor presentation highlighted a resilient topline performance despite challenges such as transient costs and weather conditions. Key segments reported varied results: the Oil Palm Business saw a 14% EBIT growth, while the Animal Nutrition segment experienced a 15% volume growth. However, the Crop Care Business faced a revenue decline of approximately 17% due to delayed monsoon impacts. The presentation also outlined a strategic shift towards value creation, focusing on streamlining the portfolio and enhancing market-facing capabilities. Management emphasized the importance of innovation and customer-centric approaches across various business segments. The document included financial metrics, segment performance details, and updates on recent product launches and ESG initiatives.

Key takeaway: During the earnings call held on May 4, 2026, management reported a strong performance for Godrej Agrovet Limited in Q4 FY '26, with consolidated revenues reaching INR 2,333 crores, a 9% year-on-year increase. Profit before tax, excluding non-recurring items, rose by 16.8% to INR 87 crores. For the full fiscal year, revenues surpassed INR 10,000 crores, achieving INR 10,233 crores, also reflecting a 9% growth. Key segments such as Animal Nutrition and Oil Palm showed significant growth, with Animal Nutrition volumes increasing by 15% year-on-year. Management highlighted a focus on value-added products and sustainability initiatives. The Crop Care segment faced challenges due to inventory issues but showed potential for recovery. Management set a goal of double-digit revenue growth for FY '27 across various segments, emphasizing volume-driven growth and strategic shifts in product offerings. The call concluded with management expressing confidence in the company's future prospects.

Key takeaway: The investor presentation from Godrej Agrovet Limited reported the approval of the Standalone and Consolidated Audited Financial Results for the fiscal year ending March 31, 2026. The company achieved a revenue of ₹10,233 crore, marking a 9.1% year-on-year increase, and reported a profit before tax of ₹569 crore, up 17.2% from the previous year. Segment-wise, the Animal Nutrition sector showed strong growth with an 18% increase in cattle feed volumes, while the Oil Palm business experienced a 68% rise in segment results. However, the Crop Care business faced challenges due to adverse weather and regulatory disruptions. The presentation also highlighted improvements in net working capital and the completion of the SAP S/4HANA digital transformation initiative. Additionally, Godrej Agrovet emphasized its commitment to sustainability through various ESG initiatives.

Key takeaway: The investor presentation from Godrej Agrovet Limited reported that the company achieved a revenue of ₹10,233 crore for FY26, marking a 9.1% increase from FY25. The presentation highlighted a 17.2% growth in profit before tax (PBT) to ₹569 crore, with a PBT margin of 5.6%. Segment-wise, the Animal Nutrition segment showed strong performance with an 18% growth in cattle feed volumes, while the Oil Palm business experienced a 68% increase in segment results. However, the Crop Care business faced challenges due to adverse weather and regulatory disruptions, impacting volumes and margins. The presentation also noted a successful digital transformation with the completion of SAP S/4HANA Wave 1 and emphasized the company's commitment to ESG initiatives, including significant renewable energy usage and water conservation efforts. Management reported a strong focus on improving operational efficiencies and sustaining growth across segments.

Key takeaway: The investor presentation from Godrej Agrovet Limited reported the approval of standalone and consolidated audited financial results for the fiscal year ending March 31, 2026. The company achieved a revenue of ₹10,233 crore, marking a 9.1% year-on-year increase, and reported a profit before tax of ₹569 crore, up 17.2% from the previous year. Segment-wise, the animal nutrition sector showed strong growth, with an 18% increase in cattle feed volumes. The oil palm business also experienced significant growth, with a 68% rise in segment results. However, the crop care business faced challenges due to adverse weather and regulatory issues, impacting volumes and margins. The presentation highlighted a successful digital transformation initiative with SAP S/4HANA and ongoing ESG efforts, including renewable energy projects and water conservation initiatives. The shareholding pattern as of March 31, 2026, indicated a strong promoter holding of 67.7%.

Key takeaway: The investor presentation from Godrej Agrovet Limited, dated April 30, 2026, reported the approval of the Standalone and Consolidated Audited Financial Results for the fiscal year ending March 31, 2026. The document highlighted a robust performance with revenue surpassing ₹10,000 crore and all-time high profitability. Key segments such as Animal Nutrition and Oil Palm showed significant growth, with EBIT growth of 68% and 19% revenue growth, respectively. However, the Crop Care and Dairy businesses faced challenges due to adverse weather and elevated procurement costs. The presentation also detailed segment-wise performance, with a notable improvement in margins and a strong focus on ESG initiatives, including renewable energy and water conservation efforts. The document concluded with a summary of the shareholding pattern as of March 31, 2026, indicating a strong promoter holding of 67.7%.

Key takeaway: During the earnings call held on February 4, 2026, Godrej Agrovet Limited reported a strong performance for Q3 FY '26, with consolidated revenues increasing by 11% year-on-year and a 23% rise in profit before tax before exceptional items. Management highlighted significant growth in the Animal Feed segment, particularly a 21% increase in cattle feed volumes. The Vegetable Oil business also performed well, with a 27% revenue growth. Astec LifeSciences showed a recovery with a 33% revenue increase. However, the Crop Protection business faced challenges due to adverse weather conditions. Management noted a strategic shift towards branded products in the Foods segment, aiming for a higher share of value-added offerings. The company is also focusing on operational efficiencies and margin expansion across its segments. Overall, management expressed confidence in the company's growth trajectory and ongoing strategic initiatives.

Key takeaway: The investor presentation from Godrej Agrovet Limited, dated February 3, 2026, detailed the company's standalone and consolidated unaudited financial results for the quarter and nine months ending December 31, 2025. Management reported a strong performance driven by margin expansion in key portfolio businesses, with consolidated revenues increasing by 11% year-on-year to ₹2,718 crore in Q3 FY26. EBITDA improved by 13.6% to ₹260 crore, and profit before tax grew by 23.1% to ₹169 crore. The presentation highlighted challenges in the Creamline Dairy and Crop Protection segments due to adverse weather conditions. Management noted that branded salience exceeded 80%, and new product launches were emphasized as a growth strategy. The document also included updates on ESG initiatives, showcasing the company's commitment to sustainability and social responsibility.